Investigating new chemical reactions for creating important drugs
Highly Selective Catalytic Reactions of Alkenes and Alkynes Relevant to Medicinal and Process Chemistry
['FUNDING_OTHER'] · OHIO STATE UNIVERSITY · NIH-10996099
This study is exploring new ways to create medicines using special chemical reactions with certain compounds, which could lead to better and safer treatments for infections and tumors that patients might need.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OHIO STATE UNIVERSITY (nih funded) |
| Locations | 1 site (Columbus, UNITED STATES) |
| Trial ID | NIH-10996099 on ClinicalTrials.gov |
What this research studies
This research focuses on discovering new catalytic reactions involving alkenes and alkynes that can lead to the development of effective drugs. By utilizing chiral cobalt complexes, the project aims to create valuable compounds that can be used in treating various conditions, including infections and tumors. The approach emphasizes understanding the mechanisms behind these reactions to enhance their efficiency and cost-effectiveness in drug manufacturing. Patients may benefit from the resulting drugs that are designed to be more effective and safer.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals needing treatment for infections, tumors, or neurological conditions related to GABA.
Not a fit: Patients with conditions that do not respond to the types of drugs being developed, such as certain rare diseases or those requiring non-chemical interventions, may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, more effective medications for various diseases.
How similar studies have performed: Other research has shown success in developing new catalytic reactions for drug synthesis, indicating a promising avenue for this approach.
Where this research is happening
Columbus, UNITED STATES
- OHIO STATE UNIVERSITY — Columbus, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAJANBABU, T V — OHIO STATE UNIVERSITY
- Study coordinator: RAJANBABU, T V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.